SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001325812-15-000050
Filing Date
2015-06-10
Accepted
2015-06-10 16:34:32
Documents
2
Period of Report
2015-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 1542
2 EDGAR SUPPORTING DOCUMENT gros_060915poa.txt EX-24 3987
  Complete submission text file 0001325812-15-000050.txt   6933
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 220 MARLBOROUGH STREET #6 BOSTON MA 02116
Business Address
Gros David-Alexandre C (Reporting) CIK: 0001644489 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36407 | Film No.: 15923816